Form 4: Curtiss-Wright CFO Sells Shares Under 10b5-1 Plan

Curtiss-Wright's CFO, K. Christopher Farkas, sold 5,047 shares of common stock for an average price of $577.91 per share under a pre-arranged 10b5-1 plan.

Summary

• K. Christopher Farkas, Vice President and CFO of Curtiss-Wright Corporation (CW), reported the sale of common stock.
• The transaction involved the disposition of 5,047 shares of common stock.
• The shares were sold on November 11, 2025, at an average price of $577.91 per share.
• The selling price ranged from $574.14 to $579.17 per share.
• Following the transaction, Farkas beneficially owns 4,236 shares directly.
• The sale was conducted under a Rule 10b5-1 plan adopted on August 11, 2025.
• The sale complies with the company's share ownership guidelines.

Sentiment

Score: 6

Explanation: The sale of shares by a CFO is generally viewed as neutral to slightly negative. However, the execution under a pre-arranged 10b5-1 plan and compliance with company ownership guidelines mitigate potential negative interpretations, suggesting a planned liquidity event rather than a reaction to new information.

Positives

• The sale was executed under a pre-arranged Rule 10b5-1 plan, indicating it was not based on new, non-public information.
• The reporting person remains in compliance with the company's share ownership guidelines after the sale.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived as a lack of confidence, though this is mitigated by the 10b5-1 plan.

Future Outlook

NA

Management Comments

• Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
• Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on August 11, 2025 and maintained by the Reporting Person's financial advisor.
• The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $574.14 to $579.17, inclusive.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.

Corporate Governance

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the pre-planned nature of the sale under a 10b5-1 plan typically minimizes concerns about management's confidence in the company's future.

Key Dates

Keywords

Curtiss-Wright, CW, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CFO, K. Christopher Farkas, Equity Transaction